Metabolic consequences of LDHA inhibition by epigallocatechin gallate and oxamate in MIA PaCa-2 pancreatic cancer cells

Metabolomics

Volumn 11, Issue 1, 2015, Pages 71-80

  Lu, Qing Yi ^a   Zhang, Lifeng ^a   Yee, Jennifer K ^b   Go, Vay Liang W ^a   Lee, Wai Nang ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

EGCG; Human pancreatic cancer MIA PaCa 2 cells; Oxamate; Tracer based metabolomics

Indexed keywords

EID: 84939888469     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-014-0672-8     Document Type: Article

References (40)

1. Bardeesy, N., & DePinho, R. A. (2002). Pancreatic cancer biology and genetics. Nature Reviews Cancer,2(12), 897–909. doi:10.1038/nrc949.
2. Boren, J., Cascante, M., Marin, S., Comin-Anduix, B., Centelles, J. J., Lim, S., et al. (2001). Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. Journal of Biological Chemistry,276(41), 37747–37753. doi:10.1074/jbc.M105796200.
3. Boros, L. G., Bassilian, S., Lim, S., & Lee, W. N. (2001). Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: A new mechanism of controlling tumor growth. Pancreas,22(1), 1–7.
4. Boros, L. G., Puigjaner, J., Cascante, M., Lee, W. N., Brandes, J. L., Bassilian, S., et al. (1997). Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Research,57(19), 4242–4248.
5. Boros, L. G., Torday, J. S., Lim, S., Bassilian, S., Cascante, M., & Lee, W. N. (2000). Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Research,60(5), 1183–1185.
6. Deberardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008). Brick by brick: Metabolism and tumor cell growth. Current Opinion in Genetics & Development,18(1), 54–61. doi:10.1016/j.gde.2008.02.003.
7. Fantin, V. R., St-Pierre, J., & Leder, P. (2006). Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell,9(6), 425–434. doi:10.1016/j.ccr.2006.04.023.
8. Goldman, R. D., Kaplan, N. O., & Hall, T. C. (1964). Lactic dehydrogenase in human neoplastic tissues. Cancer Research,24, 389–399.
9. Granchi, C., Roy, S., Giacomelli, C., Macchia, M., Tuccinardi, T., Martinelli, A., et al. (2011). Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells. Journal of Medicinal Chemistry,54(6), 1599–1612. doi:10.1021/jm101007q.
10. Harris, D. M., Li, L., Chen, M., Lagunero, T. L., Go, V. L. W., & Boros, L. G. (2012). Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: A comparative glucose tracer study with the fatty acid synthase inhibitor C75. Metabolomics,8(2), 201–210.
11. Hiura, A., Tsutsumi, M., & Satake, K. (1997). Inhibitory effect of green tea extract on the process of pancreatic carcinogenesis induced by N-nitrosobis-(2-oxypropyl)amine (BOP) and on tumor promotion after transplantation of N-nitrosobis-(2-hydroxypropyl)amine (BHP)-induced pancreatic cancer in Syrian hamsters. Pancreas,15(3), 272–277.
12. Hsu, P. P., & Sabatini, D. M. (2008). Cancer cell metabolism: Warburg and beyond. Cell,134(5), 703–707. doi:10.1016/j.cell.2008.08.021.
13. Jeoung, N. H., Rahimi, Y., Wu, P., Lee, W. N., & Harris, R. A. (2012). Fasting induces ketoacidosis and hypothermia in PDHK2/PDHK4-double-knockout mice. Biochemical Journal,443(3), 829–839. doi:10.1042/BJ20112197.
14. Jones, R. G., & Thompson, C. B. (2009). Tumor suppressors and cell metabolism: A recipe for cancer growth. Genes & Development,23(5), 537–548. doi:10.1101/gad.1756509.
15. Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., et al. (2010). Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proceedings of the National Academy of Sciences of the United States of America,107(5), 2037–2042. doi:10.1073/pnas.0914433107.
16. Lee, W. N. (1996). Stable isotopes and mass isotopomer study of fatty acid and cholesterol synthesis. A review of the MIDA approach. Advances in Experimental Medicine and Biology,399, 95–114.
17. Lee, W. N., Boros, L. G., Puigjaner, J., Bassilian, S., Lim, S., & Cascante, M. (1998). Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose. American Journal of Physiology,274(5 Pt 1), E843–E851.
18. Lee, W. N., Edmond, J., Bassilian, S., & Morrow, J. W. (1996). Mass isotopomer study of glutamine oxidation and synthesis in primary culture of astrocytes. Developmental Neuroscience,18(5–6), 469–477.
19. Lee, W. N., Guo, P., Lim, S., Bassilian, S., Lee, S. T., Boren, J., et al. (2004). Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment. British Journal of Cancer,91(12), 2094–2100. doi:10.1038/sj.bjc.6602243.
20. Leimer, K. R., Rice, R. H., & Gehrke, C. W. (1977). Complete mass spectra of N-trifluoroacetyl-n-butyl esters of amino acids. Journal of Chromatography,141(2), 121–144.
21. Li, Y., Zhang, T., Jiang, Y., Lee, H. F., Schwartz, S. J., & Sun, D. (2009). (−)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2. Molecular Pharmaceutics,6(4), 1152–1159. doi:10.1021/mp900037p.
22. Liu, S., Wang, X. J., Liu, Y., & Cui, Y. F. (2013). PI3 K/AKT/mTOR signaling is involved in (−)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells. American Journal of Chinese Medicine,41(3), 629–642. doi:10.1142/S0192415X13500444.
23. Ma, D., Wang, J., Zhao, Y., Lee, W. N., Xiao, J., Go, V. L., et al. (2012). Inhibition of glycogen phosphorylation induces changes in cellular proteome and signaling pathways in MIA pancreatic cancer cells. Pancreas,41(3), 397–408. doi:10.1097/MPA.0b013e318236f022.
24. Majima, T., Tsutsumi, M., Nishino, H., Tsunoda, T., & Konishi, Y. (1998). Inhibitory effects of beta-carotene, palm carotene, and green tea polyphenols on pancreatic carcinogenesis initiated by N-nitorsobis(2-oxopropyl)amine in Syrian golden hamsters. Pancreas,16(1), 13–18.
25. Papaconstantinou, J., & Colowick, S. P. (1961). The role of glycolysis in the growth of tumor cells. II. The effect of oxamic acid on the growth of HeLa cells in tissue culture. Journal of Biological Chemistry,236, 285–288.
26. Qanungo, S., Das, M., Haldar, S., & Basu, A. (2005). Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis,26(5), 958–967. doi:10.1093/carcin/bgi040.
27. Ramos-Montoya, A., Lee, W. N., Bassilian, S., Lim, S., Trebukhina, R. V., Kazhyna, M. V., et al. (2006). Pentose phosphate cycle oxidative and nonoxidative balance: A new vulnerable target for overcoming drug resistance in cancer. International Journal of Cancer,119(12), 2733–2741. doi:10.1002/ijc.22227.
28. Rong, Y., Wu, W., Ni, X., Kuang, T., Jin, D., Wang, D., et al. (2013). Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumour Biology,34(3), 1523–1530. doi:10.1007/s13277-013-0679-1.
29. Sanchez-Tena, S., Alcarraz-Vizan, G., Marin, S., Torres, J. L., & Cascante, M. (2013). Epicatechin gallate impairs colon cancer cell metabolic productivity. Journal of Agriculture and Food Chemistry,61(18), 4310–4317. doi:10.1021/jf3052785.
30. Semenza, G. L., Jiang, B. H., Leung, S. W., Passantino, R., Concordet, J. P., Maire, P., et al. (1996). Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. Journal of Biological Chemistry,271(51), 32529–32537.
31. Shankar, S., Ganapathy, S., Hingorani, S. R., & Srivastava, R. K. (2008). EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Frontiers in Bioscience,13, 440–452.
32. Surh, Y. J. (2003). Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer,3(10), 768–780.
33. Takada, M., Nakamura, Y., Koizumi, T., Toyama, H., Kamigaki, T., Suzuki, Y., et al. (2002). Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas,25(1), 45–48.
34. Thornburg, J. M., Nelson, K. K., Clem, B. F., Lane, A. N., Arumugam, S., Simmons, A., et al. (2008). Targeting aspartate aminotransferase in breast cancer. Breast Cancer Research,10(5), R84. doi:10.1186/bcr2154.
35. Wahjudi, P. N., Patterson, M. E., Lim, S., Yee, J. K., Mao, C. S., & Lee, W. N. (2010). Measurement of glucose and fructose in clinical samples using gas chromatography/mass spectrometry. Clinical Biochemistry,43(1–2), 198–207. doi:10.1016/j.clinbiochem.2009.08.028.
36. Wang, J., Zhang, X., Ma, D., Lee, W. N., Xiao, J., Zhao, Y., et al. (2013). Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells. Experimental Hematology & Oncology,2(1), 18. doi:10.1186/2162-3619-2-18.
37. Yang, C. S., Wang, X., Lu, G., & Picinich, S. C. (2009). Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance. Nature Reviews Cancer,9(6), 429–439. doi:10.1038/nrc2641.
38. Yasui, K., Tanabe, H., Miyoshi, N., Suzuki, T., Goto, S., Taguchi, K., et al. (2011). Effects of (−)-epigallocatechin-3-O-gallate on expression of gluconeogenesis-related genes in the mouse duodenum. Biomedical Research,32(5), 313–320.
39. Zhang, H., Cao, R., Lee, W. N., Deng, C., Zhao, Y., Lappe, J., et al. (2010). Inhibition of protein phosphorylation in MIA pancreatic cancer cells: Confluence of metabolic and signaling pathways. Journal of Proteome Research,9(2), 980–989. doi:10.1021/pr9008805.
40. Zhang, L., Pang, E., Loo, R. R., Rao, J., Go, V. L., Loo, J. A., et al. (2011). Concomitant inhibition of HSP90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic cancer HPAF-II cells. Proteomics,11(24), 4638–4647. doi:10.1002/pmic.201100242.